Eli Lilly (LLY) Other Working Capital Changes (2009 - 2026)

Eli Lilly (LLY) has reported Other Working Capital Changes for 18 consecutive years, with -$175.0 million the latest figure, recorded in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$175.0 million, down 136.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 69.97% YoY), and the FY2025 annual result was $6.6 billion, up 98.41% from the prior year.
• Other Working Capital Changes was -$175.0 million for Q1 2026 at Eli Lilly, down from $5.9 billion in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.9 billion in Q4 2025 and troughed at -$4.9 billion in Q3 2025.
• Average Other Working Capital Changes over 5 years is $639.9 million, with a median of $298.6 million recorded in 2024.
• Year-over-year, Other Working Capital Changes sank 319.57% in 2023 and jumped 16253.92% in 2025.
• Over 5 years, Other Working Capital Changes stood at $481.4 million in 2022, then slipped by 9.39% to $436.2 million in 2023, then sank by 60.82% to $170.9 million in 2024, then soared by 3368.4% to $5.9 billion in 2025, then sank by 102.95% to -$175.0 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$175.0 million in Q1 2026, $5.9 billion in Q4 2025, and -$4.9 billion in Q3 2025.